The future of weight loss treatment is looking to get easier to swallow. Several research teams and pharmaceutical companies ...

Here are the steps to take to get GLP-1s for weight loss covered by insurance, plus how to appeal denied claims and alternative weight loss options.

The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this limitation through advanced molecular engineering techniques.

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The pill also improved cardiovascular risk factors and physical activity levels.

Led by the renowned bariatric surgeon Dr. Amit Taggar, the family-owned practice marks one year of patient-centered, advanced weight loss surgery in Tampa, FL. At TWLI, patients are treated like ...

June 11 (Reuters) - The weight-loss drug market is booming, with biotech firms racing to capture a slice of a fast-growing ...

Novo Nordisk’s experimental weekly shot CagriSema was shown to lead to less dramatic weight loss compared to rival Lilly’s Tirzepatide, the drug behind Zepbound and Mounjaro, in an 84-week trial, Novo ...

If you’ve been a victim of weight-loss gimmicks, you know no amount of fad diets and trendy workouts will help you lose weight and keep it off. The endless cycle of losing and re-gaining only stops ...

Dr. Harikiran Chekuri's tummy tuck procedures help weight-loss patients restore body contours, confidence, comfort, and ...

GLP-1 receptor agonists (GLP-1 RAs) produced meaningful weight loss in patients with cirrhosis. Although those with compensated disease did not face notable muscle loss, those with decompensated ...

"Our study showed that a distance-based approach produced similar weight loss to more intensive, in-person interventions, demonstrating that this kind of program could be administered to larger groups ...